Sandip Shah

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +10

Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022

Tricia Aden, Patricia Blevins, Shannon Whitman York et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 63 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

Andrew J.S. Coats, Venkatesan Srinivasan, J Surendran et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 59 citations · Full text

Medicine, Oncology, Pharmacology +15

HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study

Martin Maiers, Michael Halagan, Sangeeta Joshi et al. · The Lancet Haematology · 2014 · 45 citations

Life Sciences, Genetics, Immunology +16

Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial

Jörge E. Cortes, Cármino Antônio De Souza, Manuel Ayala et al. · The Lancet Haematology · 2016 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9